• Join our community
  • Instagram
  • Youtube
  • Facebook

Dr Prem Kumar Nair

Group Chief Executive Officer

Date of Appointment1 October 2023

Dr Prem Kumar Nair

NationalitySingaporean

GenderMale

Age64 (As at 1 April 2025)

Dr Prem Kumar Nair was appointed Group Chief Executive Officer of IHH Healthcare on 1 October 2023, where he leads a team of more than 70,000 employees to realise IHH’s vision to be the world’s most trusted healthcare services network.

Dr Nair sets the strategic direction for the sustainable growth of IHH’s global network which today comprises more than 80 hospitals in 10 countries. Guided by its Care. For Good. aspiration, Dr Nair continues to build on the IHH portfolio of strong and reputable brands including Acibadem, Mount Elizabeth, Prince Court, Gleneagles, Fortis, Pantai, Parkway and Island - to touch lives and transform care globally.

Before his role as Group CEO, he served as CEO of IHH Singapore since 2020, where he oversaw the country’s business units and played a pivotal role in strategic growth and international outreach. Prior to that, Dr Nair was with Raffles Medical Group for 27 years, where he held concurrent roles as Chief Corporate Officer, and Managing Director for Singapore Healthcare.

With over three decades of experience as a physician and healthcare executive in both public and private sectors, Dr Nair has earned accolades such as Wellbeing CEO at the WorkWell Leaders Award 2024 and Asia’s Best CEO at the Corporate Governance Asia - Asian Excellence Award 2024.

An active community citizen in Singapore, Dr. Nair was a recipient of the Public Service Medal (Pingat Bakti Masyarakat) in 2010 and, at the 2022 National Day Awards, he received both the Public Service Star (Bintang Bakti Masyarakat) and the Public Service Medal (PBM COVID-19), respectively, for his contributions to the Singapore Prison Service and his support of national COVID-19 efforts. He is also a Justice of the Peace and an Adjunct Associate Professor at the National University of Singapore’s Saw Swee Hock School of Public Health.

Academic/Professional Qualification(s)

  • Bachelor of Medicine & Surgery, National University of Singapore
  • Master of Business Administration (Distinction), Manchester Business School, United Kingdom

Notes

  • Does not have any family relationships with any directors and/or major shareholders of the Company.
  • Dr Prem Kumar Nair has less than 5% equity interest in a fund that has invested in Leo Cancer Care. During the financial year, Dr Prem Kumar Nair had declared his potential conflict of interest (COI) in respect of IHH’s participation in research consortium for upright radiotherapy formed by Leo Cancer Care. To ensure that all potential COI issues are properly addressed, he had not been involved/shall not be involved in such transaction in any manner at all times and shall abstain from all deliberations, discussions, and votings, where relevant, on IHH’s investment decision in Leo Cancer Care at IHH level.
  • Does not have any convictions for offences within the past five years other than for traffic offences, if any.
HOSPITALS
PRIMARY CARE
ANCILLARY SERVICES
  • Parkway Radiology Logo
  • Acibadem Labmed Logo
  • Parkway Laboratories Logo
  • Agilus Diagnostics Logo
  • Parkway Laboratories
  • Premier Integrated Labs Logo
  • Premier Integrated Rehab Logo